C4 Therapeutics CEO Andrew Hirsch receives $21M in 2020
C4 Therapeutics reports 2020 executive compensation
By ExecPay News
Published: April 26, 2021
C4 Therapeutics reported fiscal year 2020 executive compensation information on April 26, 2021.
In 2020, six executives at C4 Therapeutics received on average a compensation package of $6M, a 183% increase compared to previous year.
Average pay of disclosed executives at C4 Therapeutics
Andrew J. Hirsch, Chief Executive Officer, received $21M in total. 99% of Hirsch's compensation, or $21M, was in option awards. Hirsch also received $99K in non-equity incentive plan, $168K in salary, as well as $5.6K in other compensation.
Marc A. Cohen, Chief Executive Officer, received a compensation package of $9.1M. 99% of the compensation package, or $9.1M, was in option awards.
William T. McKee, Chief Financial Officer, earned $2.1M in 2020.
Adam S. Crystal, Chief Medical Officer, received $1.6M in 2020, which decreases by 5% compared to 2019.
Stewart Fisher, Chief Scientific Officer, earned $1.6M in 2020, a 241% increase compared to previous year.
Andrew Phillips, Chief Executive Officer, received $618K in 2020, which decreases by 85% compared to 2019.
Related executives
Andrew Hirsch
C4 Therapeutics
Chief Executive Officer
Marc Cohen
C4 Therapeutics
Chief Executive Officer
Andrew Phillips
C4 Therapeutics
Chief Executive Officer
William McKee
C4 Therapeutics
Chief Financial Officer
Adam Crystal
C4 Therapeutics
Chief Medical Officer
Stewart Fisher
C4 Therapeutics
Chief Scientific Officer
You may also like
Source: SEC filing on April 26, 2021.